5Van Assche G,Dignass A,Panes J,et al. The second Eu- ropean evidence-hased consensns on tb.e diagnosis and management of CrohnJs disease:Definitions and diagnosis [J]. J Crohns Colitis,2010,4(1):7 27.
6Murakami Y, Matsui T, Hirai F, et al. Efficacy of azathio- prine in mild or moderate relapse in Crohn's disease: clini- cal and endoscopic evaluation[J] Dig Endosc, 2010, 22 (1) :25-32.
7Bernstein CN, Fried M, Krabshuis JH, et al. World Gas- troenterology Organization Practice Guidelines for the di- agnosis and management of IBD in 2010[J]. Inflamm Bowel Dis,2010,16(1) :112-124.
8Hanauer SB,Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with6-mercap- topu-rine,mesalamine, or placebo : a 2-year trial [J]. Gas- troenterology, 2004,127 (3) : 723-729.
9Akobeng AK,Zachos M. Tumor necrosis factor-alpha an tibody for induction of remission in Crohn's disease[J]. Cochrane Database Syst Rev, 2004 (1) : CD003574.
10Li Y,Lopez R. Adalimumab therapy in Crohn's disease of the ileal pouch[J]. Inflamm Bowel Dis,2012,18(12) :2232-2239.
